The diagnosis of active TB

Similar documents
Clinical Practice Guideline

THE EARLY DIAGNOSIS OF PULMONARY TUBERCULOSIS

At the end of this session, participants will be able to:

INDEX CASE INFORMATION

TB in Corrections Phoenix, Arizona

TB Clinical Guidelines: Revision Highlights March 2014

Tuberculosis Tools: A Clinical Update

Diagnosis and Medical Management of Latent TB Infection

The Air We Share: Principles and Practices of TB Infection Control

My heart is racing. Managing Complex Cases. Case 1. Case 1

TB In Detroit 2011* Early TB: Smudge Sign. Who is at risk for exposure to or infection with TB? Who is at risk for TB after exposure or infection?

TB Program Management San Antonio, Texas November 5-7, 2008

Latent TB, TB and the Role of the Health Department

Diagnosis and Treatment of Tuberculosis, 2011

Fundamentals of Tuberculosis (TB)

Using Xpert to discontinue airborne isolation The Consensus Statement

TUBERCULOSIS CONTACT INVESTIGATION

Supplemental Figure 1. Gating strategies for flow cytometry and intracellular cytokinestaining

Tuberculosis (TB) and Infection Control PICNET Conference April 12, 2013

Tuberculosis What you need to know. James Zoretic M.D., M.P.H. Regions 2 and 3 Director

Appendix B. Recommendations for Counting Reported Tuberculosis Cases (Revised July 1997)

What you need to know about diagnosing and treating TB: a preventable, fatal disease. Bob Belknap M.D. Denver Public Health November 2014

TUBERCULOSIS. Pathogenesis and Transmission

TB CONTROL IN HEALTHCARE FACILITIES: A PRACTICAL GUIDE FOR PREVENTION

Utilizing All the Tools in the TB Toolbox

Tuberculosis and Diabetes Mellitus. Lana Kay Tyer, RN MSN WA State Department of Health TB Nurse Consultant

Interpretation of Chest Radiographs Paul Christensen, MD 10/21/09. Diagnostic Evaluation. Medical Evaluation & CXR Interpretation.

Northwestern Polytechnic University

TB facts & figures Microbiology of TB Transmission of TB Infection control in health care settings Special cases Resistant TB Masks

Stop TB Poster (laminated copies are available from TB Control: )

TUBERCULOSIS. Presented By: Public Health Madison & Dane County

Tuberculosis Procedure ICPr016. Table of Contents

Communicable Disease Control Manual Chapter 4: Tuberculosis

Diagnosis & Medical Case Management of TB Disease. Lisa Armitige, MD, PhD October 22, 2015

TB: Management in an era of multiple drug resistance. Bob Belknap M.D. Denver Public Health November 2012

NATIONAL TUBERCULOSIS PREVALENCE SURVEY 2016

Contact Investigation

TB Contact Investigation

Managing the Patients Response to TB Treatment

TB Nurse Assessment. Ginny Dowell, RN, BSN October 21, 2015

Let s Talk TB A Series on Tuberculosis, A Disease That Affects Over 2 Million Indians Every Year

CHAPTER 3: DEFINITION OF TERMS

TB the basics. (Dr) Margaret (DHA) and John (INZ)

Chapter 22. Pulmonary Infections

TB is Global. Latent TB Infection (LTBI) Sharing the Care: Working Together. September 24, 2014

Chapter 7 Tuberculosis (TB)

Essential Mycobacteriology Laboratory Services in the Era of MDR- and XDR-TB: A TB Controller s Perspective

Pediatric TB Lisa Armitige, MD, PhD September 28, 2011

Tuberculosis Populations at Risk

An Introduction to Radiology for TB Nurses

Learning Objectives: Case 1 11/12/2015. Tuberculosis: Focus on Transmission and Pathogenesis. TB: Some Important Terms

Contracts Carla Chee, MHS May 8, 2012

Tuberculosis Intensive

Primary Care and TB Control Dr Helen Booth Consultant Thoracic Physician, UCLH Clinical Lead, Integrated TB NCL-Service

Latent Tuberculosis Infection (LTBI) Questions and Answers for Health Care Providers

Tuberculosis & Refugees in Philadelphia

Tuberculosis Among Children in the Republic of the Marshall Islands

TB Infection Control in Healthcare Settings

Errors in Dx and Rx of TB

Contact Investigation Overview

Infection Prevention and Control Annual Education Authored by: Infection Prevention and Control Department

2018 Tuberculosis Clinical Intensive: Infection Prevention & Control. > No disclosures

Disclosure. Objectives

Asking the Right Questions. A Visual Guide to Tuberculosis Case Management for Nurses. Reference Guide

TB Radiology for Nurses Garold O. Minns, MD

Rehuka Khurana, MD, MPH has the following disclosures to make:

Dr Francis Ogaro MTRH ELDORET

Tuberculosis Elimination: The Role of the Infection Preventionist

TB in the Patient with HIV

TB and Respiratory Protection

Pediatric Tuberculosis Lisa Y. Armitige, MD, PhD September 14, 2017

Tuberculosis Pathogenesis

Treatment of TB Infection Lisa Y. Armitige, MD, PhD April 7, 2015

3/25/2012. numerous micro-organismsorganisms

What s New in TB Infection Control?

2017/2018 Annual Volunteer Tuberculosis Notice

Core Curriculum on Tuberculosis: What the Clinician Should Know

Chapter 4 Diagnosis of Tuberculosis Disease

TB Classification (ATS/CDC)

Respiratory Tuberculosis (TB)

Investigation of Contacts of Persons with Infectious Tuberculosis, 2005

Frequently asked questions about Tuberculosis (TB) screening & prevention

Contact Investigation and Prevention in the USA

UC DavisTB Screening Requirement: How to submit your TB Health Assessment Form

CLINICAL FEATURES IN PULMONARY TUBERCULOSIS

Rebecca O. Sanchez, BSN., RN., MPH. has the following disclosures to make:

Tuberculosis. Impact of TB. Infectious Disease Epidemiology BMTRY 713 (A. Selassie, DrPH)

Targeted Testing and the Diagnosis of. Latent Tuberculosis. Infection and Tuberculosis Disease

Clinical Radiological Pathological Conference

Treatment of Tuberculosis, 2017

HEALTH SERVICES POLICY & PROCEDURE MANUAL

New Tuberculosis Guidelines. Jason Stout, MD, MHS

Etiological Agent: Pulmonary Tuberculosis. Debra Mercer BSN, RN, RRT. Definition

TB Intensive Houston, Texas. Childhood Tuberculosis Kim Connelly Smith. November 12, 2009

TB in Children. Rene De Gama Block 10 Lectures 2012

MEMORANDUM. Re: Guidance for follow-up of newly-arrived individual with Class B1 Tuberculosis Pulmonary Tuberculosis, no treatment

TUBERCULOSIS (TB) SCREENING AND TESTING

Mycobacterial Infections: What the Primary Provider Should Know about Tuberculosis

Transcription:

The diagnosis of active TB

Faculty/Presenter Disclosure Faculty: Martha Ainslie Relationships with commercial interests: Speakers Bureau/Honoraria: Boehringer Ingelheim

Mitigating Potential Bias I have received no commercial support from any company that has commercial interests in the diagnosis or treatment of tuberculosis.

Who cares about active TB?

Current status of TB in FN and Inuit TB rates in 2014 Inuit: 198/100 000 FN on reserve: 20/100 000 (incidence ranged from 26-106/100 000 from 2000-2012 in Northern Manitoba) FN off reserve: 15/100 000 Metis: 3/ 100 000 Canadian others: 4/100 000

Definition of active TB MTB complex= M TB M Bovis M africanum M Canetti Positive culture or significant evidence of disease with compatible xray changes, pathology or post mortem evidence of infection, or clinically active non-respiratory TB

In order to develop active TB you must have been Exposed to a patient with infectious TB (respiratory or laryngeal) You have to inhale the TB bacilli and become infected You are unable to contain the infection and get progressive primary disease or the infection becomes active several months to years after the initial infection ( most common scenario)

Probability of Transmission Infectiousness of person with TB Number of infectious particles produced Environment in which exposure occurred Air circulation UV light exposure Duration of exposure Virulence of the organism

Infectiousness of Patient with TB Number of particles produced Smear positive or negative Extent of disease Type of disease (laryngeal TB) Cavity (increases the number of particles by 5-6 logs)

Canadian Tuberculosis Standards 2000

Diagnosing active tuberculosis Think about 1. Are the patient s symptoms suggestive of TB 2. What is the probability that the patient has been exposed to a person with active respiratory TB? 3. Does the patient s have underlying medical issues that will predispose them to developing active TB? 4. What does the CXR show?

Signs and symptoms Insidious Symptoms present for weeks to months Pulmonary symptoms absent in 30% who only have constitutional symptoms Dyspnea seen in < 50% of patients Exam is often normal

Think about TB Cough>3 weeks and Weight loss Night sweats Fever>2 weeks Hemoptysis Fatigue Failure to improve with a course of antibiotics Unexplained weight loss

Pre test probability What is the likelihood that this person has been exposed to an infectious case of TB in their lifetime? Lived in First Nations community Immigrant from country with high prevalence of TB (don t forget the Canadian born children) Travel to a country with high prevalence Incarceration, homelessness, intravenous drug use Health care worker Close contact of an infectious case

Canadian Tuberculosis Standards 2013

CXR in the diagnosis of active TB Typical findings 90% have infiltrate in apicoposterior segment of UL or superior segments of LL Loss of volume Cavitation: seen in later stage and in patients with vigorous immune system. Often not seen in patients who are immunocomprimised

Limitations of CXR Atypical features on CXR are seen in patients with HIV, renal failure, diabetes, solid organ transplant or on chronic steroids CXR may not show cavitation May have a LL or RML infiltrate May have hilar or mediastinal adenopathy (especially in HIV patients) If any CXR abnormality is considered the sensitivity of the CXR is 95% HIV patients or patients who are close contacts to an infectious case can have a normal CXR

What to do when you suspect TB?

If you suspect pulmonary TB N95 mask if you are about to see the patient Get sputum as a first step Isolation Tell the patient to stay at home until you have made some phone calls The patient may be eligible for home isolation Contact your local TB team for advice on how to proceed Phone HSC and ask to speak to the respirologist taking outside calls Talk to ID specialist on call

Sputum Sputum for AFB and culture 3 sputa, can be collected on the same day at least 1 hour apart. Each sputum sample should be 5 ml Deliver to lab within 1 hour, if patient can t then refrigerate and protect from light AFB staining Rapid In pulmonary TB a single smear has a sensitivity of 60% Need an estimated 10 000 organisms per ml to be smear positive, need only 10-100 organisms to have a positive culture Not all that is AFB + is TB. NAAT to confirm on Smear + cases Negative smears do not rule out TB Must await cultures which can take 6 weeks If we have a high pre-test probability we may start therapy while awaiting cultures

Pulmonary TB samples Yields on samples Sputum expectorated/induced (90%) Bronchoscopy (70%) Gastric aspirates (70%) Smear and culture assessment Smear positive (5,000 to 10,000 Bacteria/ml) Culture positive (10-100 Bacteria/ml)

TST and TB disease in adults TST used to diagnose prior infection and not disease. A negative test does not rule out TB disease and a positive test does not rule in prior TB infection. TST will be negative in 20-30% of patients with active disease. Do NOT use to diagnose TB disease in adults

Summary Determine the pre-test probability that the patient has come into close contact with an infectious case of TB over their lifetime Does the patient have medical issues that would increase the risk of reactivation? If you are concerned about possible TB order a CXR Always consider in UL airspace disease especially if it is cavitated or in a nonresolving pneumonia Obtain sputum for AFB x 3. Can be collected on the same day If you get a positive AFB smear or culture or have a suspicious CXR then call your local TB expert